Placental growth hormone is increased in the maternal and fetal serum of patients with preeclampsia.
OBJECTIVE
Placental growth hormone (PGH) is a pregnancy-specific protein produced by syncytiotrophoblast and extravillous cytotrophoblast. No other cells have been reported to synthesize PGH Maternal. PGH Serum concentration increases with advancing gestational age, while quickly decreasing after delivery of the placenta. The biological properties of PGH include somatogenic, lactogenic, and lipolytic functions. The purpose of this study was to determine whether the maternal serum concentrations of PGH change in women with preeclampsia (PE), women with PE who deliver a small for gestational age neonate (PE + SGA), and those with SGA alone.


METHODS
This cross-sectional study included maternal serum from normal pregnant women (n = 61), patients with severe PE (n = 48), PE + SGA (n = 30), and SGA alone (n = 41). Fetal cord blood from uncomplicated pregnancies (n = 16) and PE (n = 16) was also analyzed. PGH concentrations were measured by ELISA. Non-parametric statistics were used for analysis.


RESULTS
(1) Women with severe PE had a median serum concentration of PGH higher than normal pregnant women (PE: median 23,076 pg/mL (3473-94 256) vs. normal pregnancy: median 12 157 pg/mL (2617-34 016); p < 0.05), pregnant women who delivered an SGA neonate (SGA: median 10 206 pg/mL (1816-34 705); p < 0.05), as well as pregnant patients with PE and SGA (PE + SGA: median 11 027 pg/mL (1232-61 702); p < 0.05). (2) No significant differences were observed in the median maternal serum concentration of PGH among pregnant women with PE and SGA, SGA alone, and normal pregnancy (p > 0.05). (3) Compared to those of the control group, the median umbilical serum concentration of PGH was significantly higher in newborns of preeclamptic women (PE: median 356.1 pg/mL (72.6-20 946), normal pregnancy: median 128.5 pg/mL (21.6-255.9); p < 0.01). (4) PGH was detected in all samples of cord blood.


CONCLUSIONS
(1) PE is associated with higher median concentrations of PGH in both the maternal and fetal circulation compared to normal pregnancy. (2) Patients with PE + SGA had lower maternal serum concentrations of PGH than preeclamptic patients without SGA. (3) Contrary to previous findings, PGH was detectable in the fetal circulation. The observations reported herein are novel and suggest that PGH may play a role in the mechanisms of disease in preeclampsia and fetal growth restriction.
Mittal
Pooja
P
Perinatology Research Branch, NICHD/NIH/DHHS, Bethesda, Maryland, USA.
Espinoza
Jimmy
J
Hassan
Sonias
S
Kusanovic
Juan Pedro
JP
Edwin
Samuel S
SS
Nien
Jyh Kae
JK
Gotsch
Francesca
F
Than
Nandor Gabor
NG
Erez
Offer
O
Mazaki-Tovi
Shali
S
Romero
Roberto
R
D000293:Adolescent; D000328:Adult; D003430:Cross-Sectional Studies; D005260:Female; D005312:Fetal Blood / Q000737:chemistry*; D005317:Fetal Growth Retardation / Q000097:blood / Q000209:etiology; D020567:Fetal Weight / Q000502:physiology; D013006:Growth Hormone / Q000032:analysis / Q000097:blood*; D006801:Humans; D007231:Infant, Newborn; D009035:Mothers; D010926:Placental Hormones / Q000032:analysis / Q000097:blood*; D011225:Pre-Eclampsia / Q000097:blood* / Q000175:diagnosis; D011247:Pregnancy
C064980:GH2 protein, human; D010926:Placental Hormones; D013006:Growth Hormone
Clin Sci (Lond). 2007 Jan;112(1):51-7
16928195
Am J Obstet Gynecol. 2007 Apr;196(4):326.e1-13
17403407
J Clin Endocrinol Metab. 2000 Mar;85(3):1143-50
10720053
Clin Endocrinol (Oxf). 2000 Nov;53(5):645-7
11106927
Am J Obstet Gynecol. 2001 May;184(6):1267-72
11349200
J Clin Endocrinol Metab. 2001 Oct;86(10):4854-9
11600553
Biol Reprod. 2002 Mar;66(3):555-61
11870057
Am J Obstet Gynecol. 2002 Mar;186(3):512-7
11904616
Am J Pathol. 2002 Apr;160(4):1405-23
11943725
Placenta. 2002 Apr;23 Suppl A:S87-94
11978064
Kidney Int. 2006 Feb;69(3):621-4
16395263
Early Hum Dev. 2006 Apr;82(4):235-9
16337100
N Engl J Med. 2006 Apr 27;354(17):1857-8
16641410
Growth Horm IGF Res. 2006 Apr;16(2):67-85
16632396
Nat Med. 2006 Jun;12(6):642-9
16751767
Am J Obstet Gynecol. 2006 Jul;195(1):201-7
16545329
Am J Obstet Gynecol. 2006 Jul;195(1):255-9
16813756
J Exp Med. 2006 Sep 4;203(9):2165-75
16923853
N Engl J Med. 2006 Sep 7;355(10):992-1005
16957146
J Matern Fetal Neonatal Med. 2006 Oct;19(10):607-13
17118734
J Clin Endocrinol Metab. 2002 Jun;87(6):2734-9
12050242
Growth Horm IGF Res. 2002 Oct;12(5):374-80
12213191
Am J Obstet Gynecol. 2003 Jan;188(1):247-51
12548225
J Clin Endocrinol Metab. 2003 Feb;88(2):804-11
12574217
J Clin Invest. 2003 Mar;111(5):649-58
12618519
J Clin Endocrinol Metab. 2003 May;88(5):2348-51
12727995
Growth Horm IGF Res. 2004 Feb;14(1):66-70
14700557
J Clin Endocrinol Metab. 2004 Jan;89(1):384-91
14715876
J Clin Endocrinol Metab. 2004 Feb;89(2):770-5
14764795
N Engl J Med. 2004 Feb 12;350(7):672-83
14764923
Endocrinology. 2004 Mar;145(3):1144-50
14633976
Hypertens Pregnancy. 2004;23(1):101-11
15117604
Am J Obstet Gynecol. 2004 Jun;190(6):1541-7; discussion 1547-50
15284729
Am J Obstet Gynecol. 2004 Oct;191(4):1240-6
15507947
Hum Genet. 1981;57(2):138-41
6262212
Lancet. 1985 Feb 16;1(8425):399
2857451
J Clin Endocrinol Metab. 1988 Jun;66(6):1171-80
3372680
J Biol Chem. 1988 Jun 25;263(18):9001-6
3379057
Proc Natl Acad Sci U S A. 1988 Nov;85(21):8241-5
3186721
Acta Obstet Gynecol Scand. 1988;67(6):549-52
3239387
J Clin Invest. 1989 Jun;83(6):1985-91
2723069
Acta Obstet Gynecol Scand Suppl. 1989;147:1-38
2728860
Br J Obstet Gynaecol. 1989 Aug;96(8):949-53
2775694
Am J Obstet Gynecol. 1990 Feb;162(2):311-6
2309811
J Biol Chem. 1990 May 15;265(14):7939-44
2335510
Am J Physiol. 1990 Jun;258(6 Pt 1):E1014-9
2360624
Endocrinology. 1991 Mar;128(3):1298-302
1999151
Endocrinology. 1991 Oct;129(4):1779-83
1915067
Cell Tissue Res. 1992 Mar;267(3):407-12
1571954
Mol Cell Endocrinol. 1993 Apr;92(2):R7-13
8319824
Am J Physiol. 1993 Oct;265(4 Pt 1):E572-7
8238332
Pediatr Res. 1993 Oct;34(4):439-42
8255674
Acta Paediatr Suppl. 1994 Apr;399:49-51; discussion 52
7949617
Horm Res. 1994;42(4-5):207-14
7868075
Obstet Gynecol. 1996 Feb;87(2):163-8
8559516
Br J Obstet Gynaecol. 1997 Feb;104(2):223-8
9070144
Am J Reprod Immunol. 1997 Oct;38(4):302-6
9352019
Am J Obstet Gynecol. 1997 Nov;177(5):1003-10
9396883
Am J Obstet Gynecol. 1997 Dec;177(6):1526-34
9423763
Eur J Endocrinol. 1998 Jul;139(1):54-8
9703379
Fetal Diagn Ther. 1998 Sep-Oct;13(5):291-7
9813422
Scand J Clin Lab Invest. 1998 Aug;58(5):373-81
9819186
Am J Obstet Gynecol. 1998 Dec;179(6 Pt 1):1539-44
9855593
Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1246-51
9990009
JAMA. 2005 Jan 5;293(1):77-85
15632339
Clin Obstet Gynecol. 2005 Jun;48(2):372-86
15805796
J Matern Fetal Neonatal Med. 2005 Jan;17(1):3-18
15804781
Endocrinology. 2005 May;146(5):2434-44
15718272
Pediatr Res. 2005 May;57(5 Pt 2):1R-7R
15817508
Placenta. 2005 Aug;26(7):563-73
15993706
Eur J Obstet Gynecol Reprod Biol. 2005 Sep 1;122(1):33-9
15935542
Mediators Inflamm. 2005 Oct 24;2005(5):293-7
16258196
J Soc Gynecol Investig. 2006 Jan;13(1):40-7
16303323
Growth Horm IGF Res. 2006 Oct-Dec;16(5-6):290-6
16996762